- Home
- HIHO vs GTBP Comparison
HIHO vs GTBP Comparison
Compare HIHO & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIHO
- GTBP
- Stock Information
- Founded
- HIHO 1990
- GTBP 1965
- Country
- HIHO Hong Kong
- GTBP United States
- Employees
- HIHO N/A
- GTBP N/A
- Industry
- HIHO Industrial Machinery/Components
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- HIHO Industrials
- GTBP Health Care
- Exchange
- HIHO Nasdaq
- GTBP Nasdaq
- Market Cap
- HIHO 8.2M
- GTBP 6.6M
- IPO Year
- HIHO 1996
- GTBP N/A
- Fundamental
- Price
- HIHO $1.93
- GTBP $3.01
- Analyst Decision
- HIHO
- GTBP
- Analyst Count
- HIHO 0
- GTBP 0
- Target Price
- HIHO N/A
- GTBP N/A
- AVG Volume (30 Days)
- HIHO 40.6K
- GTBP 23.3K
- Earning Date
- HIHO 10-10-2024
- GTBP 11-14-2024
- Dividend Yield
- HIHO 3.66%
- GTBP N/A
- EPS Growth
- HIHO N/A
- GTBP N/A
- EPS
- HIHO N/A
- GTBP N/A
- Revenue
- HIHO $7,648,000.00
- GTBP N/A
- Revenue This Year
- HIHO N/A
- GTBP N/A
- Revenue Next Year
- HIHO N/A
- GTBP N/A
- P/E Ratio
- HIHO N/A
- GTBP N/A
- Revenue Growth
- HIHO 10.41
- GTBP N/A
- 52 Week Low
- HIHO $1.70
- GTBP $1.92
- 52 Week High
- HIHO $2.88
- GTBP $10.66
- Technical
- Relative Strength Index (RSI)
- HIHO 47.27
- GTBP 53.54
- Support Level
- HIHO $1.89
- GTBP $2.73
- Resistance Level
- HIHO $2.08
- GTBP $3.20
- Average True Range (ATR)
- HIHO 0.06
- GTBP 0.34
- MACD
- HIHO -0.00
- GTBP -0.04
- Stochastic Oscillator
- HIHO 20.42
- GTBP 36.73
About HIHO Highway Holdings Limited
Highway Holdings Ltd is a holding company. The company is a manufacturer of metal, plastic, electric and electronic components for original equipment manufacturers (OEM) and contract manufacturers. Its operating segment includes Metal stamping and mechanical OEM and Electric OEM. The metal stamping segment focuses on the manufacturing and sale of metal parts and components. The company generates maximum revenue from the Metal stamping and mechanical OEM segment. Geographically, it derives a majority of its revenue from Europe and also has a presence in Hong Kong and China, North America, and Other Asian countries.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.